News | Radiation Therapy | July 22, 2024

Company to introduce significant product upgrades that enable treating multiple tumors in a single treatment plan to improve patient experience

Researchers from multiple clinical programs will present scientific evidence in 37 oral and poster presentations at the 2024 AAPM annual meeting, confirming the efficacy and feasibility of the RefleXion X1 machine with SCINTIX biology-guided radiotherapy.

Researchers from multiple clinical programs will present scientific evidence in 37 oral and poster presentations at the 2024 AAPM annual meeting, confirming the efficacy and feasibility of the RefleXion X1 machine with SCINTIX biology-guided radiotherapy. (Photo: Business Wire)

  •  

July 22, 2024 — RefleXion Medical, an external-beam theranostic oncology company, today announced that researchers from multiple clinical programs will present pioneering scientific evidence in 37 oral and poster presentations confirming the efficacy and feasibility of the RefleXion X1 machine with SCINTIX® biology-guided radiotherapy (BgRT) at the 2024 American Association of Physicists in Medicine (AAPM) Annual Meeting in Los Angeles, July 21-25.

“Since last year’s AAPM, we have begun delivering SCINTIX therapy in the clinic, which required a significant effort to characterize and establish standards for this first-in-world radiotherapy approach. This year, we have 37 presentations that collectively reflect this collaborative effort between physicists, clinicians and researchers,” said Sean Shirvani, M.D., chief medical officer of RefleXion. “The rigor of our research, the scientific collaboration, and the potential impact on patient care are truly inspiring.”

The following four oral presentations and programs highlight new research showcasing the potential of SCINTIX therapy to optimize multi-target treatment planning with high dosimetric accuracy, the nuances of clinical workflows, the accuracy of multi-target SCINTIX therapy, and an introduction to BIGSTAR (Biological Image Guidance for Spatial-Temporally Adaptive Radiotherapy), an innovative approach that aims to enhance cancer patient management and treatment outcomes by focusing on intra-fraction immune response to direct adaptive radiotherapy based on tumor biology. Detailed information on all 37 presentations may be found here.

Oral Presentations and Invited Programs:

Oral: Initial Dosimetric Performance of Multi-Target, Multi-Treatment Area Image-Guided Radiotherapy in a Single Session, Mason Hazlett, M.S.
Sunday, July 21, 1:42 pm in Room 152

Invited Program: PET Guided Radiation Therapy 101, Dae Yup Han, Ph.D.
Tuesday, July 23, 8:06 am in Room 502A

Invited Program: Introduction and Overview of Current Technology for Biology-guided RT, Dae Yup Han, Ph.D.
Thursday, July 25, 8:30 am, Room 502A

Oral: Pulsar – a Biology-guided Radiotherapy Strategy That Optimizes Immuno-Radiotherapy Based on Intra-Fraction Immune Response, Robert Timmerman, M.D.
Thursday, July 25, 8:44 am, Room 502A

RefleXion is also hosting an industry lunch symposium during the AAPM annual meeting at 12:30 PM CDT on July 22. Physicists Murat Surucu, Ph.D., Arnold Pompos, Ph.D., Tyler Watkins, Ph.D., and David Carlson, Ph.D. will share their latest clinical experience with SCINTIX biology-guided radiotherapy, highlight early clinical cases and share Quality Assurance (QA) procedures and practices.

The company will also hold interactive SCINTIX technology demonstrations in its booth (#1407) focused on its recent product release that includes the ability to treat multiple targets, both SCINTIX therapy and SBRT targets, in a single treatment plan, and the availability of live PET data during treatment delivery. The rollout of these features, designed to improve the patient experience and physician confidence, is currently underway at all RefleXion installed base sites.

For more information: www.reflexion.com

Find more AAPM24 conference coverage here


Related Content

News

Aug. 5, 2024 — Researchers from The University of Texas MD Anderson Cancer Center have demonstrated that adding ...

Time August 09, 2024
arrow
News | PET-CT

July 31, 2024 — In a head-to-head comparison with FDG PET/CT, FDG PET/MRI demonstrated comparable or superior diagnostic ...

Time July 31, 2024
arrow
News | Radiology Business

July 31, 2024 — The American Registry of Radiologic Technologists (ARRT) announced the three Registered Technologists (R ...

Time July 31, 2024
arrow
Feature | Radiation Oncology | By Christine Book

News emerging from several leading organizations and vendors in the radiation therapy arena came in at a fast pace in ...

Time July 30, 2024
arrow
News | Radiopharmaceuticals and Tracers

July 24, 2024 — Telix Pharmaceuticals Limited announced that the United States (U.S.) Food and Drug Administration (FDA) ...

Time July 24, 2024
arrow
News | ASTRO

July 18, 2024 — The members of the American Society for Radiation Oncology (ASTRO) recently elected five new officers to ...

Time July 18, 2024
arrow
News | PET-CT

July 16, 2024 — A new research paper was published in Oncotarget's Volume 15 on June 20, 2024, titled, “Comparison of ...

Time July 16, 2024
arrow
News | Digital Pathology

July 12, 2024 — AGFA HealthCare, a global leader in healthcare imaging management solutions, announced that Enterprise ...

Time July 12, 2024
arrow
News | Digital Pathology

July 12, 2024 — Diagnosing cancer and providing the personalized therapy it often requires, is a collaborative effort ...

Time July 12, 2024
arrow
Feature | Imaging Technology News - ITN

Be sure to check out the latest digital edition of Imaging Technology News (ITN), featuring the Mobile C-arm Systems ...

Time July 11, 2024
arrow
Subscribe Now